Current role
Biotechnology · Healthcare
Chairman
2021-08-02–present
Michael W. Bonney
Chairman
Alnylam Pharmaceuticals, Inc. (ALNY)Equibles does not estimate personal net worth.
Get an email with a short summary when Alnylam Pharmaceuticals, Inc. publishes a filing, an earnings call transcript or a press release.
Get ALNY alertsAbout Michael W. Bonney
Michael W. Bonney is recorded as Chairman at Alnylam Pharmaceuticals, Inc. (ALNY) since August 2, 2021. Alnylam Pharmaceuticals, Inc. reported in an 8-K filed December 3, 2025 that Michael W. Bonney resigned as director of the Board of Directors, effective December 2, 2025. Alnylam Pharmaceuticals, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Alnylam Pharmaceuticals, Inc. includes Yvonne Greenstreet (CEO and COO), Yvonne L. Greenstreet (CEO, COO and Board Member), Amy W. Schulman (Chairman and Board Member) and 7 others.
“On December 2, 2025, Michael W. Bonney and Carolyn Bertozzi, Ph.D. provided notice of each of their resignations from the Board of Directors (the “Board”) of Alnylam Pharmaceuticals, Inc. (the “Company”), effective on the same date.”
Affiliation history
-
Current
2021-08-02–present
Company network
Leadership on record at Alnylam Pharmaceuticals, Inc.
- Yvonne Greenstreet CEO, COO
- Yvonne L. Greenstreet CEO, COO, Board Member
- Amy W. Schulman Chairman, Board Member
- Michael Bonney Chairman
- Jeffrey Poulton CFO
- Manmeet S CFO
- Akshay K. Vaishnaw, M.D., Ph.D. CIO
- Benjamin F. Cravatt Board Member
- Benjamin F. Cravatt, Ph.D. Board Member
- Carolyn R. Bertozzi Board Member